• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, October 27, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Drugs & Therapy Perspectives Thanks Its Peer Reviewers for 2026

by
October 27, 2026
in Health
Reading Time: 6 mins read
0
Drugs & Therapy Perspectives Thanks Its Peer Reviewers for 2026

Drugs & Therapy Perspectives Thanks Its Peer Reviewers for 2026

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The final issue of Drugs & Therapy Perspectives for 2026 opens not with a research paper but with a letter of thanks. The piece, titled simply “Acknowledgement to Referees,” was published on 27 October 2026 and is available as open access, meaning readers have full access to its content without a subscription barrier.

The letter begins by welcoming readers to the closing issue of the year and stating the journal’s intention to look back on what has been accomplished. The editors single out two groups whose contributions they describe as crucial to the journal’s continued success: the authors who submitted and published articles over the course of 2026, and the reviewers who assessed them. The enthusiasm of authors for their chosen fields, the editors write, and their willingness to contribute content, are described as essential to keeping the journal running.

Alongside the acknowledgements, the editorial discloses a set of 2025 performance metrics for the journal. According to the letter, Drugs & Therapy Perspectives recorded an Impact Factor of 0.6, a CiteScore of 1.0, and 163,900 article downloads. The median time from submission to first decision was reported as 8 days. These figures offer a quantitative snapshot of the journal’s standing and operational speed, and they are presented by the editors as context for the year in review rather than as claims of record performance.

The core of the publication is a roll call of names. The editors state that the quality of published articles is a testament to the diligence of peer reviewers, whose willingness to share their expertise ensures the journal’s content is held to a high standard. They then list the individuals who acted as reviewers for the journal in the last twelve months. The list is international in scope, spanning reviewers affiliated with institutions and practices across Africa, the Americas, Asia, Australia, Europe and the Middle East.

Reading through the reviewer roster gives a sense of the journal’s global reach. Named reviewers include Heba A. Abdelkader of Egypt, Jacob N. Ablin of Israel, Hind Abouzahir of Morocco, Dimitrios Adamis of Greece, Chiamaka B. Agbaetuo of Nigeria, Rohini Agrawal of India, Bilal Ahmad of Pakistan, and Syed S. Ahmed of India, among many others. Further down the list appear Lorenzo Ala of Italy, Mohammed Al-Badri of Iraq, Mohammed Alahmadi of Saudi Arabia, Zainab Ali of Qatar, Huda K. Alqudah of Jordan, Demetra Antimisiaris of the United States, Ahmed I. Anwar of the United States, and Jason Bacharach of the United States.

The list continues with reviewers such as Filip Baert of Belgium, Haleh Bagheri of France, Ilknur Basyigit of Türkiye, Anna-belle Beau of France, Charles L. Bennett of the United States, John E. Bennett of the United States, Michael Berger of the United States, Filip Bielec of Poland, Anne-Marie Bisgaard of Denmark, Riley Bowers of the United States, Antonio Brucato of Italy, Anna Brusch of Australia, Yannick Buccella of Switzerland, and Craig Campbell of Canada. Other named reviewers include Yi Chai of China, Amrita Chakraborty of India, Shao-Ping Chang of Taiwan, Jing Chen of China, Jingguo Chen of China, Arrigo F. G. Cicero of Italy, Samuel D. Cohen of France, and Juan R. Correa-Perez of the United States.

Additional reviewers acknowledged in the letter include Lena Daher of France, Elin Dahlén of Sweden, Qiang Y. Deng of China, Sahil B. Desai of India, Danilo Di Lorenzo of Italy, Giovanni Battista Di Nardo of Italy, Joseph A. Dikun of the United States, Mihail Dishev of the United Kingdom, Asena C. Dogramaci of Türkiye, Myrene R. Dsouza of India, Mahdi El Husseini of the Islamic Republic of Iran, Omnia F. El-Rashidy of Egypt, Fatma Etgü of Türkiye, Beng Eu of Australia, William Everett of the United States, Jialiu Fang of China, Hugo F. Fernandez of the United States, Mary-Ann Fitzcharles of Canada, Regina Folster-Holst of Germany, and Livio Garattini of Italy. The list also names Andrea Gill of the United Kingdom, Paul Grootendorst of Canada, Mary Hedges of the United States, Ashleigh Hooimeyer of Australia, Daniel B. Horton of the United States, Moninne Howlett of Ireland, Anna M. Hu of the United States, Angela Jeong of the United States, Ripu D. Jindal of the United States, Shamir Kalaria of the United States, Hye-Young Kang of the Republic of Korea, Radin Karimi of the United Kingdom, and Ozgur Kasapcopur of Türkiye.

The acknowledgements extend further, naming Fatima Kathrada of South Africa, Belayneh Kefale of Australia, Pragyanshu Khare of India, Inderdeep S. Kochar of India, Eitaro Kodani of Japan, Cecelia Koetting of the United States, Dimitra Koumaki of Greece, Mathilde C. M. Kouwenhoven of The Netherlands, Anthony L. Kovac of the United States, Doris Laçej of Italy, Dominique Larrey of France, Tomas Lasys of The Netherlands, Terri L. Levien of the United States, Joel Lexchin of Canada, Geoffrey O. Littlejohn of Australia, Jimin N. Liu of Canada, Adrián López García de Lomana of Iceland, Barbara Lortal of France, Mario Luciano of Italy, Peter Lüthje of Finland, Monia M. Marchetti of Italy, Monica Margoni of Italy, Henry Michael of Canada, Aye Moh-Moh-Aung of Malaysia, Andrew Mosholder of the United States, Barbara Mostacci of Italy, Maddalena Napolitano of Italy, Joanna Nowaczyk of Germany, Per Nydert of Sweden, Elena Orlandi of Italy, Ipek Betul Ozcivit Erkan of Türkiye, Shanthi Pal of Switzerland, Katrina Peariso of the United States, Mary Petrulis of the United States, Arwen H. Pieterse of The Netherlands, Francesco Pignatti of the United Kingdom, Tatjana S. Potpara of Serbia, Yash Prashar of India, Giulia Prato of Italy, Athina Pyrpasopoulou of Greece, Giovanna Russo of Italy, Amber Salisbury of the United Kingdom, Stefan Sandulache of Romania, G. Santulli of the United States, Jyotirmoy Sarker of the United States, Vittorio Sartorelli of the United States, Takehito Sato of Japan, Shane Scahill of New Zealand, Joanne L. Sharp of the United Kingdom, Muhammad Shawqi of Egypt, Şaban Melih Şimşek of Türkiye, Michael Sinha of the United States, Anne S. Sølling of Denmark, Amit K. Srivastava of India, Marina Talamonti of Italy, Ozgur Tanriverdi of Türkiye, Helena Teede of Australia, Stephen Tomlin of the United Kingdom, Federica Trovato of Italy, Pedro Luiz Serrano Uson Junior of Brazil, Erwin van Wegen of The Netherlands, Albert I. Wertheimer of the United States, Michael C. Woodward of Australia, Thasia G. Woodworth of the United States, Tadele M. Yadesa of Uganda, Nadir Yalcin of Türkiye, Serkan Yazici of Türkiye, Mutong Zhao of China, Yan Zhao of China, Zhenlai Zhu of China, and Focke Ziemssen of Germany.

Beyond the reviewer roster, the editorial expresses gratitude to the members of the journal’s Honorary Editorial Board, who the editors say have acted as peer reviewers and authors and have provided guidance on journal content, policy and processes. The board’s Editors Emeriti are listed as Richard Day of Australia, William H. Frishman of the United States, David J. Greenblatt of the United States, Hannelore Kreckel of Germany, and Howard I. Maibach of the United States. The Editorial Board itself is likewise international, including Habeeb Ibrahim Abdul Razack of Saudi Arabia, Mohammed Aldhaeefi of the United States, Abdullah Al Hamid of Saudi Arabia, Yousef A. Alomi of Saudi Arabia, Sabina A. Antoniu of Romania, André R. T. S. Araujo of Portugal, Francisco Araujo of Spain, Mohamed Baraka of the United Arab Emirates, Julio Bassas-Vila of Spain, Margarida Caramona of Portugal, Natalia Cebotarenco of Moldova, Surarong Chinwong of Thailand, Rui Cruz of Portugal, Paola Maria Cutroneo of Italy, Shereen Elazzazy of Qatar, David Hachey of the United States, Martina Hahn of Germany, Syed S. Hasan of the United Kingdom, Satisha Hegde of India, Raquel Herrera Comoglio of Argentina, Abubakar M. Isa of Nigeria, Jimmy Jose of Oman, David Liew of Australia, Ye H. Linn of Myanmar, Chen Liu of China, Imran Manji of Kenya, Wardati Mazlan-Kepli of Malaysia, Barbara E. McKenzie of the United Kingdom, Sanja Mirkov of Australia, Manuel Morgado of Portugal, Harikrishnan Parthasarathy of India, Florjana Rustemi of Albania, Sandeep Saluja of India, Rima Shah of India, Alok Singh of India, Brian Spoelhof of the United States, Matej Stuhec of Slovenia, Monica Tarapués of Ecuador, Thierry Trenque of France, Kirsten K. Viktil of Norway, Antony M. S. Wang of Taiwan, and William Zirker of the United States.

The letter closes on a forward-looking note. The editors write that they hope readers have found the articles published throughout the year interesting and informative, and they confirm that the editorial schedule for 2027 is already well under way, with the journal looking forward to bringing readers what it describes as many high-quality and authoritative articles over the coming year. The message is signed with best wishes by Nitin Joshi and Anton van Rensburg, co-editors-in-chief of Drugs & Therapy Perspectives.

Subject of Research: Annual editorial acknowledgement of peer reviewers and editorial board members of Drugs & Therapy Perspectives, with 2025 journal metrics

Article Title: Acknowledgement to Referees

Article References: Acknowledgement to Referees. (2026). Drugs & Therapy Perspectives. https://doi.org/10.1007/s40267-026-01281-6 (Author names are not included in the publisher’s citation export.)

Image Credits: AI Generated

DOI: 10.1007/s40267-026-01281-6

Keywords: peer review, Drugs & Therapy Perspectives, editorial acknowledgement, journal metrics, Impact Factor, CiteScore, open access, scientific publishing, editorial board, reviewers, 2026, academic journals

News Source: Ophelia Keating. (October 27, 2026). Drugs & Therapy Perspectives Thanks Its Peer Reviewers for 2026. Scienmag.

Tags: 2026academic journalsCiteScoreDrugs & Therapy Perspectiveseditorial acknowledgementeditorial boardimpact factorjournal metricsopen accesspeer reviewreviewersscientific publishing
Share12Tweet7Share2ShareShareShare1

Related Posts

Urban Coastal Sediments Reveal Contrasting Fingerprints of Human and Natural Particle Inputs

Urban Coastal Sediments Reveal Contrasting Fingerprints of Human and Natural Particle Inputs

October 27, 2026
Kidney Radiation Doses Stay Low in Most Men After PSMA Therapy

Kidney Radiation Doses Stay Low in Most Men After PSMA Therapy

October 27, 2026

Fifteen Years of Subclavian Artery Occlusion Devices Have Not Yet Proven Better Outcomes

October 27, 2026

Mirabegron beats tamsulosin at easing ureteral stent symptoms in randomized trial

October 27, 2026

POPULAR NEWS

  • Classroom redesigns, active breaks, and active lessons cut children's sitting time, review finds

    Classroom redesigns, active breaks, and active lessons cut children’s sitting time, review finds

    29 shares
    Share 12 Tweet 7
  • Can Genes and Gut Microbes Predict Who Responds to Semaglutide for Liver Disease?

    29 shares
    Share 12 Tweet 7
  • Italy’s Oldest National Park Opens Decades of Alpine Vegetation Data to the World

    29 shares
    Share 12 Tweet 7
  • Injectable aripiprazole linked to fewer hospitalizations in bipolar disorder

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Kidney Radiation Doses Stay Low in Most Men After PSMA Therapy

Drugs & Therapy Perspectives Thanks Its Peer Reviewers for 2026

Plate waste and small portions reveal gaps in Indonesia’s free school meal program

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.